AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2013
Feb 11, 2013
30583_dirs_2013-02-11_cf2e1ead-1466-450b-8771-4e5be3a9394c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2013-01-22
Reporting Person: MEIER RICHARD A (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-01-22 | Common Stock | M | 5000 | $16.92 | Acquired | 23650 | Direct |
| 2013-01-22 | Common Stock | S | 5000 | $55.00 | Disposed | 18650 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-01-22 | Stock Option (right to buy) | $16.92 | M | 5000 | Disposed | 2016-12-13 | Common Stock (5000) | Direct |
Footnotes
F1: Transaction made pursuant to a Rule 10b5-1 Trading plan executed on December 11, 2012.
F2: Options vest 1/4th each on March 14, 2007, June 14, 2007, September 14, 2007 and December 14, 2007.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19